Aptuit has divested its aseptic clinical manufacturing site in Glasgow, UK to Albany Molecular Research, Inc. (AMRI), and has entered into a definitive agreement to sell its West Lafayette, IN solid-state chemistry business (SSCI) for a total consideration of $60 million. AMRI paid $24 million for the Glasgow business, and, subject to certain closing conditions, will pay the remaining $36 million for the West Lafayette business and will assume certain liabilities related to that subsidiary. AMR...